Navigation Links
Controversial Study to Test Link Between Insomnia and Sleep Apnea

Measuring Prevalence of Sleep Apnea Among Insomnia Patients

ALBUQUERQUE, N.M., Feb. 9 /PRNewswire/ -- The Sleep and Human Health Institute (SHHI) was awarded a grant to study one of the most controversial aspects of Chronic Insomnia. Conventional wisdom connects insomnia to psychological factors -- stress, racing thoughts, and worries -- and is usually treated with sleeping pills or talk therapy. Pitted against the CW is the provocative theory that a large percentage of Chronic Insomniacs suffer from Obstructive Sleep Apnea (OSA), a physical breathing problem that might cause unwanted or unexpected sleeplessness.

Several leading sleep researchers have espoused this theory for the last decade; and Philips Respironics, a world leader in the treatment of obstructive sleep apnea, has awarded a $50,000 grant to co-sponsor the study in Albuquerque, NM to measure the occurrence of OSA in Chronic Insomnia patients.

"The Sleep and Human Health Institute has a history of groundbreaking work, and this study will be an important advancement in understanding the relationship between Insomnia and Sleep Apnea," said David P. White, M.D., Chief Medical Officer, Philips Respironics. "We know there are many skeptics who insist Chronic Insomnia is largely a psychological problem, but recent studies on certain patients have already shown that continuous positive airway pressure (CPAP) therapy or upper airway surgery significantly decreases insomnia."

Unlike other studies that investigated patients at sleep centers, the new research will examine randomly selected patients seeking care at their primary care clinics. This approach provides data much closer to what goes on in the general population compared to sleep center cohorts.

"This opportunity will clarify whether Sleep Apnea is a common problem often overlooked in Chronic Insomnia patients," declared Dr. Barry Krakow, principal investigator and medical director of the Sleep & Human Health Institute. "We'll be using the latest respiratory technology to more accurately measure breathing, and we hypothesize that more than half of these Chronic Insomnia patients will suffer from previously undiagnosed Sleep Apnea." Dr. Krakow is also medical director of Maimonides Sleep Arts and Sciences, a co-sponsor of the research.

SOURCE Sleep and Human Health Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
2. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
3. New Study Shares Benchmarks for Fixed-Dose Combination (FDC) Drug Development
4. New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
5. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
6. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
7. New Study Provides Benchmarks for Winning Brand Team Management
8. New Study Shares Insights for Competitive Intelligence Policies, Ethics and Data Collection
9. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
10. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
11. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):